RAFAEL HOLDINGS, INC. Loans and Leases Receivable, Allowance
RAFAEL HOLDINGS, INC. (RFL) had Loans and Leases Receivable, Allowance of $25.00 million as of 2021-10-31, per its 10-Q/A filed 2022-02-28.
Discontinued › Notes › ASU 2016-13 Transition
us-gaap:LoansAndLeasesReceivableAllowance · last filed 2022-02-28
- 2021-10-31: Loans and Leases Receivable, Allowance $25.00M.
| Period end | Loans and Leases Receivable, Allowance |
|---|---|
| 2021-10-31 | $25.00M 10-Q/A · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |